2024-04-012025-03-312025-03-31false13261831ORAL HEALTHCARE WALDRON LTD2025-06-18falseiso4217:GBPxbrli:pure132618312024-03-31132618312025-03-31132618312024-04-012025-03-31132618312023-03-31132618312024-03-31132618312023-04-012024-03-3113261831bus:SmallEntities2024-04-012025-03-3113261831bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3113261831bus:FullAccounts2024-04-012025-03-3113261831bus:PrivateLimitedCompanyLtd2024-04-012025-03-3113261831core:WithinOneYear2025-03-3113261831core:AfterOneYear2025-03-3113261831core:WithinOneYear2024-03-3113261831core:AfterOneYear2024-03-3113261831core:ShareCapital2025-03-3113261831core:SharePremium2025-03-3113261831core:RevaluationReserve2025-03-3113261831core:OtherReservesSubtotal2025-03-3113261831core:RetainedEarningsAccumulatedLosses2025-03-3113261831core:ShareCapital2024-03-3113261831core:SharePremium2024-03-3113261831core:RevaluationReserve2024-03-3113261831core:OtherReservesSubtotal2024-03-3113261831core:RetainedEarningsAccumulatedLosses2024-03-3113261831core:LandBuildings2025-03-3113261831core:PlantMachinery2025-03-3113261831core:Vehicles2025-03-3113261831core:FurnitureFittings2025-03-3113261831core:OfficeEquipment2025-03-3113261831core:NetGoodwill2025-03-3113261831core:IntangibleAssetsOtherThanGoodwill2025-03-3113261831core:ListedExchangeTraded2025-03-3113261831core:UnlistedNon-exchangeTraded2025-03-3113261831core:LandBuildings2024-03-3113261831core:PlantMachinery2024-03-3113261831core:Vehicles2024-03-3113261831core:FurnitureFittings2024-03-3113261831core:OfficeEquipment2024-03-3113261831core:NetGoodwill2024-03-3113261831core:IntangibleAssetsOtherThanGoodwill2024-03-3113261831core:ListedExchangeTraded2024-03-3113261831core:UnlistedNon-exchangeTraded2024-03-3113261831core:LandBuildings2024-04-012025-03-3113261831core:PlantMachinery2024-04-012025-03-3113261831core:Vehicles2024-04-012025-03-3113261831core:FurnitureFittings2024-04-012025-03-3113261831core:OfficeEquipment2024-04-012025-03-3113261831core:NetGoodwill2024-04-012025-03-3113261831core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113261831core:ListedExchangeTraded2024-04-012025-03-3113261831core:UnlistedNon-exchangeTraded2024-04-012025-03-3113261831core:MoreThanFiveYears2024-04-012025-03-3113261831core:Non-currentFinancialInstruments2025-03-3113261831core:Non-currentFinancialInstruments2024-03-3113261831dpl:CostSales2024-04-012025-03-3113261831dpl:DistributionCosts2024-04-012025-03-3113261831core:LandBuildings2024-04-012025-03-3113261831core:PlantMachinery2024-04-012025-03-3113261831core:Vehicles2024-04-012025-03-3113261831core:FurnitureFittings2024-04-012025-03-3113261831core:OfficeEquipment2024-04-012025-03-3113261831dpl:AdministrativeExpenses2024-04-012025-03-3113261831core:NetGoodwill2024-04-012025-03-3113261831core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113261831dpl:GroupUndertakings2024-04-012025-03-3113261831dpl:ParticipatingInterests2024-04-012025-03-3113261831dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3113261831core:ListedExchangeTraded2024-04-012025-03-3113261831dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3113261831core:UnlistedNon-exchangeTraded2024-04-012025-03-3113261831dpl:CostSales2023-04-012024-03-3113261831dpl:DistributionCosts2023-04-012024-03-3113261831core:LandBuildings2023-04-012024-03-3113261831core:PlantMachinery2023-04-012024-03-3113261831core:Vehicles2023-04-012024-03-3113261831core:FurnitureFittings2023-04-012024-03-3113261831core:OfficeEquipment2023-04-012024-03-3113261831dpl:AdministrativeExpenses2023-04-012024-03-3113261831core:NetGoodwill2023-04-012024-03-3113261831core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3113261831dpl:GroupUndertakings2023-04-012024-03-3113261831dpl:ParticipatingInterests2023-04-012024-03-3113261831dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3113261831core:ListedExchangeTraded2023-04-012024-03-3113261831dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3113261831core:UnlistedNon-exchangeTraded2023-04-012024-03-3113261831core:NetGoodwill2025-03-3113261831core:IntangibleAssetsOtherThanGoodwill2025-03-3113261831core:LandBuildings2025-03-3113261831core:PlantMachinery2025-03-3113261831core:Vehicles2025-03-3113261831core:FurnitureFittings2025-03-3113261831core:OfficeEquipment2025-03-3113261831core:AfterOneYear2025-03-3113261831core:WithinOneYear2025-03-3113261831core:ListedExchangeTraded2025-03-3113261831core:UnlistedNon-exchangeTraded2025-03-3113261831core:ShareCapital2025-03-3113261831core:SharePremium2025-03-3113261831core:RevaluationReserve2025-03-3113261831core:OtherReservesSubtotal2025-03-3113261831core:RetainedEarningsAccumulatedLosses2025-03-3113261831core:NetGoodwill2024-03-3113261831core:IntangibleAssetsOtherThanGoodwill2024-03-3113261831core:LandBuildings2024-03-3113261831core:PlantMachinery2024-03-3113261831core:Vehicles2024-03-3113261831core:FurnitureFittings2024-03-3113261831core:OfficeEquipment2024-03-3113261831core:AfterOneYear2024-03-3113261831core:WithinOneYear2024-03-3113261831core:ListedExchangeTraded2024-03-3113261831core:UnlistedNon-exchangeTraded2024-03-3113261831core:ShareCapital2024-03-3113261831core:SharePremium2024-03-3113261831core:RevaluationReserve2024-03-3113261831core:OtherReservesSubtotal2024-03-3113261831core:RetainedEarningsAccumulatedLosses2024-03-3113261831core:NetGoodwill2023-03-3113261831core:IntangibleAssetsOtherThanGoodwill2023-03-3113261831core:LandBuildings2023-03-3113261831core:PlantMachinery2023-03-3113261831core:Vehicles2023-03-3113261831core:FurnitureFittings2023-03-3113261831core:OfficeEquipment2023-03-3113261831core:AfterOneYear2023-03-3113261831core:WithinOneYear2023-03-3113261831core:ListedExchangeTraded2023-03-3113261831core:UnlistedNon-exchangeTraded2023-03-3113261831core:ShareCapital2023-03-3113261831core:SharePremium2023-03-3113261831core:RevaluationReserve2023-03-3113261831core:OtherReservesSubtotal2023-03-3113261831core:RetainedEarningsAccumulatedLosses2023-03-3113261831core:AfterOneYear2024-04-012025-03-3113261831core:WithinOneYear2024-04-012025-03-3113261831core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3113261831core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3113261831core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3113261831core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3113261831core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3113261831core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3113261831core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113261831core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113261831core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113261831core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3113261831core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3113261831core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3113261831core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3113261831core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3113261831core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3113261831core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3113261831core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3113261831core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3113261831core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3113261831core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3113261831core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3113261831core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3113261831core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3113261831core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3113261831core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3113261831core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3113261831core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3113261831bus:Director12024-04-012025-03-31

ORAL HEALTHCARE WALDRON LTD

Registered Number
13261831
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

ORAL HEALTHCARE WALDRON LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

PATEL, Sundeep

Registered Address

74 Pentland Road
Slough
SL2 1TN

Registered Number

13261831 (England and Wales)
ORAL HEALTHCARE WALDRON LTD
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets74,489148,172
74,489148,172
Current assets
Debtors951,679464,963
Cash at bank and on hand74,88865,386
1,026,567530,349
Creditors amounts falling due within one year3(1,003,183)(601,983)
Net current assets (liabilities)23,384(71,634)
Total assets less current liabilities97,87376,538
Creditors amounts falling due after one year4(62,320)(63,876)
Net assets35,55312,662
Capital and reserves
Called up share capital100100
Profit and loss account35,45312,562
Shareholders' funds35,55312,662
The financial statements were approved and authorised for issue by the Director on 18 June 2025, and are signed on its behalf by:
PATEL, Sundeep
Director
Registered Company No. 13261831
ORAL HEALTHCARE WALDRON LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates & other similar allowances.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows: Plant and Machinery - 25% Straight Line Method. Office Equipment - 25% Straight Line Method.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20252024
Average number of employees during the year06
3.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables223,036346,569
Bank borrowings and overdrafts7,807-
Amounts owed to related parties230,052227,235
Other creditors542,28828,179
Total1,003,183601,983
4.Creditors: amounts due after one year

2025

2024

££
Trade creditors / trade payables62,32063,876
Total62,32063,876
5.Related party transactions
The intercompany balances consist entirely of related party transactions, which form part of the ultimate controlling party. The accumulated balance as at year end, owed to the company is £150,644 (2023 - £64,796).